A detailed history of Royal Bank Of Canada transactions in Femasys Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 52,935 shares of FEMY stock, worth $51,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,935
Previous 52,935 -0.0%
Holding current value
$51,346
Previous $60,000 3.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.76 - $3.89 $76 - $389
-100 Reduced 0.19%
52,935 $51,000
Q3 2023

Nov 14, 2023

BUY
$0.31 - $2.98 $31 - $298
100 Added 0.19%
53,035 $158,000
Q3 2022

Nov 14, 2022

SELL
$1.13 - $2.54 $2,511 - $5,646
-2,223 Reduced 4.03%
52,935 $60,000
Q1 2022

May 16, 2022

BUY
$1.76 - $3.99 $93,165 - $211,210
52,935 Added 2381.24%
55,158 $125,000
Q3 2021

Nov 15, 2021

BUY
$6.52 - $8.5 $14,493 - $18,895
2,223 New
2,223 $15,000

Others Institutions Holding FEMY

About FEMASYS INC


  • Ticker FEMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 11,813,600
  • Market Cap $11.5M
  • Description
  • Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...
More about FEMY
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.